143 related articles for article (PubMed ID: 1987273)
21. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.
Herrmann T; Accolla RS; MacDonald HR
Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004
[TBL] [Abstract][Full Text] [Related]
22. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
23. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
[TBL] [Abstract][Full Text] [Related]
24. Evidence for T cell receptor-HLA class II molecule interaction in the response to superantigenic bacterial toxins.
Fleischer B; Mittrücker HW
Eur J Immunol; 1991 May; 21(5):1331-3. PubMed ID: 2037017
[TBL] [Abstract][Full Text] [Related]
25. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
Sant AJ
J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).
Braun MA; Gerlach D; Hartwig UF; Ozegowski JH; Romagné F; Carrel S; Köhler W; Fleischer B
J Immunol; 1993 Mar; 150(6):2457-66. PubMed ID: 8450222
[TBL] [Abstract][Full Text] [Related]
27. Binding of staphylococcal enterotoxin A to purified murine MHC class II molecules in supported lipid bilayers.
Lee JM; Watts TH
J Immunol; 1990 Nov; 145(10):3360-6. PubMed ID: 2230121
[TBL] [Abstract][Full Text] [Related]
28. Interactions between staphylococcal superantigens and MHC class II molecules.
Labrecque N; Thibodeau J; Sékaly RP
Semin Immunol; 1993 Feb; 5(1):23-32. PubMed ID: 8467091
[TBL] [Abstract][Full Text] [Related]
29. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
[TBL] [Abstract][Full Text] [Related]
30. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the binding of staphylococcal enterotoxin D to the T cell receptor Vbeta chain and major histocompatibility complex class II.
Li Y; Zhu X; Huang Y; Xiong H
Immunol Lett; 2006 May; 105(1):55-60. PubMed ID: 16481046
[TBL] [Abstract][Full Text] [Related]
32. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule.
Fernández MM; De Marzi MC; Berguer P; Burzyn D; Langley RJ; Piazzon I; Mariuzza RA; Malchiodi EL
Mol Immunol; 2006 Mar; 43(7):927-38. PubMed ID: 16023209
[TBL] [Abstract][Full Text] [Related]
33. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
34. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.
Hedlund G; Dohlsten M; Herrmann T; Buell G; Lando PA; Segrén S; Schrimsher J; MacDonald HR; Sjögren HO; Kalland T
J Immunol; 1991 Dec; 147(12):4082-5. PubMed ID: 1753087
[TBL] [Abstract][Full Text] [Related]
35. Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.
Ishioka GY; Adorini L; Guery JC; Gaeta FC; LaFond R; Alexander J; Powell MF; Sette A; Grey HM
J Immunol; 1994 May; 152(9):4310-9. PubMed ID: 8157954
[TBL] [Abstract][Full Text] [Related]
36. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
37. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins.
Yagi J; Uchiyama T; Janeway CA
J Immunol; 1994 Feb; 152(3):1154-62. PubMed ID: 7905498
[TBL] [Abstract][Full Text] [Related]
38. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.
Dohlsten M; Lando PA; Hedlund G; Trowsdale J; Kalland T
Immunology; 1990 Sep; 71(1):96-100. PubMed ID: 2210803
[TBL] [Abstract][Full Text] [Related]
39. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
40. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vbeta specificity.
Stevens KR; Van M; Lamphear JG; Rich RR
J Immunol; 1996 Dec; 157(11):4970-8. PubMed ID: 8943403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
